CN102177137B - 1-苯基吡咯化合物 - Google Patents
1-苯基吡咯化合物 Download PDFInfo
- Publication number
- CN102177137B CN102177137B CN200980139825.9A CN200980139825A CN102177137B CN 102177137 B CN102177137 B CN 102177137B CN 200980139825 A CN200980139825 A CN 200980139825A CN 102177137 B CN102177137 B CN 102177137B
- Authority
- CN
- China
- Prior art keywords
- phenyl
- methyl
- compound
- pyrrole
- methylsulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *[C@](Cc1cc(C(Nc2cc(*)c(*)cc2)=O)c(*)[n]1-c1c(*)cc(*)cc1)OCc1ccccc1 Chemical compound *[C@](Cc1cc(C(Nc2cc(*)c(*)cc2)=O)c(*)[n]1-c1c(*)cc(*)cc1)OCc1ccccc1 0.000 description 4
- SJYDMRYFPWUZSY-UHFFFAOYSA-N CC(Nc(cc1)cc(C)c1S(C)(=O)=O)=O Chemical compound CC(Nc(cc1)cc(C)c1S(C)(=O)=O)=O SJYDMRYFPWUZSY-UHFFFAOYSA-N 0.000 description 1
- PURNCTYNCNQUJJ-SFHVURJKSA-N CCOC(c(cc1C[C@H](C)OCc2ccccc2)c(C)[n]1-c(ccc(C)c1)c1Cl)=O Chemical compound CCOC(c(cc1C[C@H](C)OCc2ccccc2)c(C)[n]1-c(ccc(C)c1)c1Cl)=O PURNCTYNCNQUJJ-SFHVURJKSA-N 0.000 description 1
- JZEBVZBEPJNOBB-AWEZNQCLSA-N CCc([n](c(C[C@H](C)O)c1)-c(cc2)c(C(F)(F)F)cc2F)c1C(Nc(cc1)ccc1S(C)(=O)=O)=O Chemical compound CCc([n](c(C[C@H](C)O)c1)-c(cc2)c(C(F)(F)F)cc2F)c1C(Nc(cc1)ccc1S(C)(=O)=O)=O JZEBVZBEPJNOBB-AWEZNQCLSA-N 0.000 description 1
- LVOCRFUBCCYZEK-INIZCTEOSA-N CCc([n](c(C[C@H](C)OCc1ccccc1)c1)-c(ccc(F)c2)c2OC(F)F)c1C(OC)=O Chemical compound CCc([n](c(C[C@H](C)OCc1ccccc1)c1)-c(ccc(F)c2)c2OC(F)F)c1C(OC)=O LVOCRFUBCCYZEK-INIZCTEOSA-N 0.000 description 1
- HPFFIMZPJPWJIO-AWEZNQCLSA-N C[C@@H](Cc1cc(C(Nc(cc2)cc(C)c2S(C)(=O)=O)=O)c(C)[n]1-c(ccc(F)c1)c1OC(F)F)O Chemical compound C[C@@H](Cc1cc(C(Nc(cc2)cc(C)c2S(C)(=O)=O)=O)c(C)[n]1-c(ccc(F)c1)c1OC(F)F)O HPFFIMZPJPWJIO-AWEZNQCLSA-N 0.000 description 1
- RJTWRYWUAYFQSU-NSHDSACASA-N C[C@@H](Cc1cc(C(Nc(cc2)cc(Cl)c2S(N)(=O)=O)=O)c(C)[n]1-c(cc1)c(C(F)(F)F)cc1Cl)O Chemical compound C[C@@H](Cc1cc(C(Nc(cc2)cc(Cl)c2S(N)(=O)=O)=O)c(C)[n]1-c(cc1)c(C(F)(F)F)cc1Cl)O RJTWRYWUAYFQSU-NSHDSACASA-N 0.000 description 1
- GTICJIREZPHVJA-NSHDSACASA-N C[C@@H](Cc1cc(C(Nc(cc2)cc(Cl)c2S(N)(=O)=O)=O)c(C)[n]1-c(ccc(Cl)c1)c1OC(F)(F)F)O Chemical compound C[C@@H](Cc1cc(C(Nc(cc2)cc(Cl)c2S(N)(=O)=O)=O)c(C)[n]1-c(ccc(Cl)c1)c1OC(F)(F)F)O GTICJIREZPHVJA-NSHDSACASA-N 0.000 description 1
- XHRVPMTUOBTMJB-LBPRGKRZSA-N C[C@@H](Cc1cc(C(Nc(cc2)cc(F)c2S(C)(=O)=O)=O)c(C)[n]1-c(ccc(F)c1)c1OC(F)F)O Chemical compound C[C@@H](Cc1cc(C(Nc(cc2)cc(F)c2S(C)(=O)=O)=O)c(C)[n]1-c(ccc(F)c1)c1OC(F)F)O XHRVPMTUOBTMJB-LBPRGKRZSA-N 0.000 description 1
- GSAYHGKIZFLKFN-UHFFFAOYSA-N Cc([n](c(CCF)c1)-c(cc2)c(C(F)(F)F)cc2Cl)c1C(Nc(cc1)ccc1S(N)(=O)=O)=O Chemical compound Cc([n](c(CCF)c1)-c(cc2)c(C(F)(F)F)cc2Cl)c1C(Nc(cc1)ccc1S(N)(=O)=O)=O GSAYHGKIZFLKFN-UHFFFAOYSA-N 0.000 description 1
- GUKPXCNCKVJPOE-UHFFFAOYSA-N Cc([n](c(CCO)c1)-c(cc2)c(C(F)(F)F)cc2Cl)c1C(Nc(cc1)ccc1S(C)(=O)=O)=O Chemical compound Cc([n](c(CCO)c1)-c(cc2)c(C(F)(F)F)cc2Cl)c1C(Nc(cc1)ccc1S(C)(=O)=O)=O GUKPXCNCKVJPOE-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/42—Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10380408P | 2008-10-08 | 2008-10-08 | |
| US61/103,804 | 2008-10-08 | ||
| PCT/US2009/059852 WO2010042626A1 (en) | 2008-10-08 | 2009-10-07 | 1-phenylpyrrole compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102177137A CN102177137A (zh) | 2011-09-07 |
| CN102177137B true CN102177137B (zh) | 2015-03-18 |
Family
ID=41328965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200980139825.9A Active CN102177137B (zh) | 2008-10-08 | 2009-10-07 | 1-苯基吡咯化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8642640B2 (enExample) |
| EP (1) | EP2349996B1 (enExample) |
| JP (2) | JP5767587B2 (enExample) |
| KR (1) | KR101671868B1 (enExample) |
| CN (1) | CN102177137B (enExample) |
| AU (1) | AU2009302375B2 (enExample) |
| BR (1) | BRPI0920551B1 (enExample) |
| CA (1) | CA2736930C (enExample) |
| ES (1) | ES2453500T3 (enExample) |
| IL (1) | IL212171A (enExample) |
| TW (2) | TWI460161B (enExample) |
| WO (1) | WO2010042626A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102177137B (zh) * | 2008-10-08 | 2015-03-18 | 埃克塞利希斯股份有限公司 | 1-苯基吡咯化合物 |
| CN104478782B (zh) * | 2015-01-13 | 2016-03-16 | 佛山市赛维斯医药科技有限公司 | 一类含烷氧苯基和二烯氟代金刚烷结构的化合物和用途 |
| CN104447484B (zh) * | 2015-01-13 | 2016-06-08 | 佛山市赛维斯医药科技有限公司 | 含烷氧苯基和二烯金刚烷结构的化合物、其制备方法和用途 |
| CN104447485A (zh) * | 2015-01-13 | 2015-03-25 | 佛山市赛维斯医药科技有限公司 | 一种含腈基苯和二烯金刚烷结构的化合物、其制备方法和用途 |
| CN104478781A (zh) * | 2015-01-13 | 2015-04-01 | 佛山市赛维斯医药科技有限公司 | 二烯金刚烷类化合物、其制备方法和用途 |
| AU2020371836B2 (en) | 2019-10-25 | 2026-01-29 | Sunshine Lake Pharma Co., Ltd. | Pyrrole amide compound and use thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006012642A2 (en) * | 2004-07-30 | 2006-02-02 | Exelixis, Inc. | Pyrrole derivatives as pharmaceutical agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI444185B (zh) | 2007-04-09 | 2014-07-11 | Daiichi Sankyo Co Ltd | 吡咯衍生物之阻轉異構物 |
| CN102177137B (zh) * | 2008-10-08 | 2015-03-18 | 埃克塞利希斯股份有限公司 | 1-苯基吡咯化合物 |
-
2009
- 2009-10-07 CN CN200980139825.9A patent/CN102177137B/zh active Active
- 2009-10-07 WO PCT/US2009/059852 patent/WO2010042626A1/en not_active Ceased
- 2009-10-07 JP JP2011531142A patent/JP5767587B2/ja active Active
- 2009-10-07 KR KR1020117010429A patent/KR101671868B1/ko not_active Expired - Fee Related
- 2009-10-07 BR BRPI0920551-9A patent/BRPI0920551B1/pt active IP Right Grant
- 2009-10-07 EP EP09793339.4A patent/EP2349996B1/en active Active
- 2009-10-07 ES ES09793339.4T patent/ES2453500T3/es active Active
- 2009-10-07 AU AU2009302375A patent/AU2009302375B2/en not_active Ceased
- 2009-10-07 US US13/122,239 patent/US8642640B2/en active Active
- 2009-10-07 CA CA2736930A patent/CA2736930C/en active Active
- 2009-10-08 TW TW098134159A patent/TWI460161B/zh active
- 2009-10-08 TW TW103129290A patent/TWI532717B/zh active
-
2011
- 2011-04-06 IL IL212171A patent/IL212171A/en active IP Right Grant
-
2014
- 2014-07-22 JP JP2014148863A patent/JP5837655B2/ja not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006012642A2 (en) * | 2004-07-30 | 2006-02-02 | Exelixis, Inc. | Pyrrole derivatives as pharmaceutical agents |
Also Published As
| Publication number | Publication date |
|---|---|
| JP5767587B2 (ja) | 2015-08-19 |
| HK1155162A1 (en) | 2012-05-11 |
| IL212171A0 (en) | 2011-06-30 |
| CN102177137A (zh) | 2011-09-07 |
| CA2736930A1 (en) | 2010-04-15 |
| TWI532717B (zh) | 2016-05-11 |
| EP2349996A1 (en) | 2011-08-03 |
| BRPI0920551B1 (pt) | 2021-12-14 |
| CA2736930C (en) | 2016-11-22 |
| JP2014196366A (ja) | 2014-10-16 |
| JP2012505226A (ja) | 2012-03-01 |
| TWI460161B (zh) | 2014-11-11 |
| TW201028376A (en) | 2010-08-01 |
| TW201514144A (zh) | 2015-04-16 |
| JP5837655B2 (ja) | 2015-12-24 |
| US8642640B2 (en) | 2014-02-04 |
| US20110263544A1 (en) | 2011-10-27 |
| AU2009302375A1 (en) | 2010-04-15 |
| WO2010042626A1 (en) | 2010-04-15 |
| KR20110091664A (ko) | 2011-08-12 |
| ES2453500T3 (es) | 2014-04-08 |
| BRPI0920551A2 (pt) | 2020-08-11 |
| EP2349996B1 (en) | 2014-01-01 |
| KR101671868B1 (ko) | 2016-11-03 |
| IL212171A (en) | 2015-11-30 |
| AU2009302375B2 (en) | 2015-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101679243B (zh) | 吡咯衍生物的阻转异构体 | |
| RU2470916C2 (ru) | Производные пиррола как лекарственные вещества | |
| JP5837655B2 (ja) | １−フェニルピロール化合物 | |
| CZ2004272A3 (cs) | Perorální antidiabetická činidla | |
| JP2011526936A (ja) | 癌の処理のための新規オルト−アミノアニリド | |
| CN102186817B (zh) | (羟烷基)吡咯衍生物的阻转异构体 | |
| US20040259891A1 (en) | Novel pyrimidon derivatives | |
| JP2010111657A (ja) | ピロール誘導体のアトロプ異性体を含有する医薬 | |
| HK1155162B (en) | 1-phenylpyrrole compounds | |
| HK1155163B (en) | Atropisomers of (hydroxyalkyl) pyrrole derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20201214 Address after: California, USA Patentee after: EXELIXIS, Inc. Address before: California, USA Patentee before: EXELIXIS, Inc. Patentee before: DAIICHI SANKYO Co.,Ltd. |